## REFERENCES

1.Nguyen, HQ, Jumaan, AO, Seward, JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. New England Journal of Medicine 2005; 352: 450–458.

2.Reynolds, MA, et al. Epidemiology of varicella hospitalizations in the United States, 1995–2005. Journal of Infectious Diseases 2008; 197 (Suppl. 2): S120–126.

3.Davis, MM, Patel, MS, Gebremariam, A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004; 114: 786–792.

4.Seward, JF, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995–2000. Journal of the American Medical Association 2002; 287: 606–611.

5.Seward, JF, Marin, M, Vazquez, M. Varicella vaccine effectiveness in the US vaccination program: a review. Journal of Infectious Diseases 2008; 197 (Suppl. 2): S82–89.

6.Kuter, B, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatric Infectious Disease Journal 2004; 23: 132–137.

7.Gould, PL, et al. An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients – Arkansas, 2006. Pediatric Infectious Disease Journal 2009; 28: 678–681.

8.Nardone, A, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007; 25: 7866–7872.

9.Heininger, U, Seward, JF. Varicella. Lancet 2006; 368: 1365–1376.

10.Siedler, A, Arndt, U. The impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Eurosurveillance 2010; 15(13): pii=19530.

11.Halloran, ME, Longini, IM, Struchiner, CJ. Design and Analysis of Vaccine Studies. New York: Springer, 2010.

12.Halloran, ME, et al. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. American Journal of Epidemiology 1994; 140: 81–104.

13.Brisson, M, et al. Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. Vaccine 2000; 18: 2775–2778.

14.Farrington, CP. Estimation of vaccine effectiveness using the screening method. International Journal of Epidemiology 1993; 22: 742–746.

15.Anderson, RM, Grenfell, BT, May, RM. Oscillatory fluctuations in the incidence of infectious disease and the impact of vaccination: time series analysis. Journal of Hygiene (London) 1984; 93: 587–608.

16.Grijalva, CG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007; 369: 1179–1186.

17.Antunes, JL, et al. Effectiveness of influenza vaccination and its impact on health inequalities. International Journal of Epidemiology 2007; 36: 1319–1326.

18.Girard, DZ. Intervention times series analysis of pertussis vaccination in England and Wales. Health Policy 2000; 54: 13–25.

19.Mullooly, JP, et al. Evaluation of the impact of an HMO's varicella vaccination program on incidence of varicella. Vaccine 2004; 22: 1480–1485.

20.Kalies, H, et al. Vaccination coverage in children can be estimated from health insurance data. BMC Public Health 2008; 8: 82.

21.R Development Core Team.R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2009.

22.Halloran, ME, Longini, IM Jr., Struchiner, CJ. Design and interpretation of vaccine field studies. Epidemiological Review 1999; 21: 73–88.

23.Bramley, JC, Jones, IG. Epidemiology of chickenpox in Scotland: 1981 to 1998. Communicable Disease and Public Health 2000; 3: 282–287.

24.Brisson, M, Edmunds, WJ, Gay, NJ. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. Journal of Medical Virology 2003; 70 (Suppl. 1): S31–37.

25.Ferguson, NM, Anderson, RM, Garnett, GP. Mass vaccination to control chickenpox: the influence of zoster. Proceedings of the National Academy of Sciences USA 1996; 93: 7231–7235.

26.Garnett, GP, Grenfell, BT. The epidemiology of varicella-zoster virus infections: a mathematical model. Epidemiology and Infection 1992; 108: 495–511.

27.Marin, M, Meissner, HC, Seward, JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics 2008; 122: E744–E751.

28.Quian, J, et al. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997–2005. Archives of Diseases in Childhood 2008; 93: 845–850.

29.Guris, D, et al. Changing varicella epidemiology in active surveillance sites – United States, 1995–2005. Journal of Infectious Diseases 2008; 197 (Suppl. 2): S71–75.

30.Bayer, O, et al. Metaanalysis of vaccine effectiveness in varicella outbreaks. Vaccine 2007; 25: 6655–6660.

31.Chaves, SS, et al. Loss of vaccine-induced immunity to varicella over time. New England Journal of Medicine 2007; 356: 1121–1129.

32.Spackova, M, et al. Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine 2010; 28: 686–691.

33.Clements, DA, et al. Postlicensure study of varicella vaccine effectiveness in a day-care setting. Pediatric Infectious Disease Journal 1999; 18: 1047–1050.

34.Seward, JF, et al. Contagiousness of varicella in vaccinated cases: a household contact study. Journal of the American Medical Association 2004; 292: 704–708.

35.Vazquez, M, et al. Effectiveness over time of varicella vaccine. Journal of the American Medical Association 2004; 291: 851–855.

36.Anon.Vaccine coverage at school health examinations in Germany, 2007 [in German]. Epidemiologisches Bulletin 2009; 16: 143–145.

37.Bader, HM, Ludwig, M. Vaccine coverage from association of SHI physicians billing: regional determination of immunization from birth until the age of 24 months 2003–2007 in the state of Schleswig-Holstein/Northern Germany. In: Abstracts of the 1st National Vaccination Conference, 5–7 March 2009, pp. 22–23 (http://www.nationale-impfkonferenz.de/media/Abstractband_5_03_09_.pdf), 2009. 38.Fahrmeir, L, Tutz, G. Multivariate Statistical Modelling Based on Generalized Linear Models, 2nd edn. New York: Springer, 2001.

39.Mebane, WR, Sekhon, JS. Robust estimation and outlier detection for overdispersed multinomial models of count data. American Journal of Political Science 2004; 48: 392–411.

40.Herzog, SA, Paul, M, Held, L. Heterogeneity in vaccination rates explains the size and occurence of measles epidemics in German surveillance data. Epidemiology and Infection. Published online: 12 July 2010. doi:10.1017/S0950268810001664.

41.McLean, AR, Anderson, RM. Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidemiology and Infection 1988; 100: 419–442.

42.Goldman, GS. The case against varicella vaccination. International Journal of Toxicology 2006; 25: 313–317.

43.Shumway, RH, Stoffer, DS. Time Series Analysis and its Applications. New York: Springer, 2000.